Global Pharmaceutical Isolators Market (High-value & Low-value): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)
The global pharmaceutical isolators market is expected to record a value of US$2.42 billion in 2026, growing at a CAGR of 11.25%, for the time period of 2022-2026. Factors such as expansion of biotechnology industry, explosive growth of cell & gene therapies in development, increasing use of high potency active pharmaceutical ingredients, rising focus on contract development manufacturing organizations (CDMOs) and regulatory framework to support adoption of pharmaceutical isolators are likely to drive the market growth. However, the growth of the market would be challenged by issues in the maintenance of pharmaceutical isolators. A few notable trends may include growing share of isolators in aseptic manufacturing market, upsurge in pharmaceutical R&D spending and automation inside isolators.
Based on tier, the global isolator market has been segmented into High-value Isolators and Low-value Isolators. Among them, the share of high-value isolators is significantly growing due to the presence of standard quality in providing sterile environment. Within the segment, premium high-value isolators are gaining high popularity due their increasing adoption by CDMOs (Contract Development Manufacturing Organizations).
The fastest growing regional market is the U.S. due to the rising development of new drugs, generic medicines, and biosimilars. Europe and Asia Pacific also held significant shares in the market, owing to the rise in investment by large pharmaceutical companies on new product launches and growth in the MA& deals among the biopharmaceutical firms.
Scope of the report:
The report provides a comprehensive analysis of the global pharmaceutical isolators market.
The major regions (the U.S., Europe, Asia Pacific and Latin America) in the pharmaceutical isolators market have been analyzed.
The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
The competitive landscape of the market, along with the company profiles of leading players (Getinge, Azbil, Skan Holding, OPTIMA (METALL+PLASTIC), Syntegon Technology and Comecer) are also presented in detail.
Key Target Audience:
Pharmaceutical Isolators Manufacturers
Raw Material Suppliers
End Users (R&D institutes and manufacturing firms)
Investment Companies
Government Bodies & Regulating Authorities
- 1. Market Overview
- 1.1 Introduction
- 1.2 Major Purpose of Pharmaceutical Isolators
- 1.3 Types of Pharmaceutical Isolators
- Table 1: Types of Pharmaceutical Isolators
- 1.4 Comparison Between Isolators and RABs
- Table 2: Summary of Deep Renovation Activities and Products
- 1.5 Arrangement of an Isolator Facility
- Table 3: Arrangement of an Isolator Facility
- 2. Impact of COVID-19
- 2.1 Surge in Vaccine Funding
- Table 4: COVID-19 Vaccine R&D Funding by Top Countries
- 2.2 Growth in FDA Approval for Biologics
- Table 5: FDA Approvals for Biologics in the U.S. (2019-2020)
- 2.3 Sterile Drug Product Manufacturing during COVID-19
- 3. Global Market Analysis
- 3.1 Global Pharmaceutical Isolator Market by Value
- Table 6: Global Pharmaceutical Isolator Market by Value (2017-2021)
- 3.2 Global Pharmaceutical Isolator Market Forecast by Value
- Table 7: Global Pharmaceutical Isolator Market Forecast by Value (2022-2026)
- 3.3 Global Pharmaceutical Isolator Market by Tier
- Table 8: Global Pharmaceutical Isolator Market by Tier (2021)
- 3.3.1 Global High-value Isolators Market by Value
- Table 9: Global High-value Isolators Market by Value (2017-2021)
- 3.3.2 Global High-value Isolators Market Forecast by Value
- Table 10: Global High-value Isolators Market Forecast by Value (2022-2026)
- 3.3.3 Global High-value Isolators Market by Tier
- Table 11: Global High-value Isolators Market by Tier (2021)
- 3.3.4 Global Premium High-value Isolators Market by Value
- Table 12: Global Premium High-value Isolators Market by Value (2017-2021)
- 3.3.5 Global Premium High-value Isolators Market Forecast by Value
- Table 13: Global Premium High-value Isolators Market Forecast by Value (2022-2026)
- 3.3.6 Global Mid-tier High-value Isolators Market by Value
- Table 14: Global Mid-tier High-value Isolators Market by Value (2017-2021)
- 3.3.7 Global Mid-tier High-value Isolators Market Forecast by Value
- Table 15: Global Mid-tier High-value Isolators Market Forecast by Value (2022-2026)
- 3.3.8 Global Low-value Isolators Market by Value
- Table 16: Global Low-value Isolators Market by Value (2017-2021)
- 3.3.9 Global Low-value Isolators Market Forecast by Value
- Table 17: Global Low-value Isolators Market Forecast by Value (2022-2026)
- 3.4 Global Pharmaceutical Isolator Market by Region
- Table 18: Global Isolator Market by Region (2021)
- 4. Regional Market Analysis
- 4.1 The U.S.
- 4.1.1 The U.S. Pharmaceutical Isolator Market by Value
- Table 19: The U.S. Pharmaceutical Isolator Market by Value (2017-2021)
- 4.1.2 The U.S. Pharmaceutical Isolator Market Forecast by Value
- Table 20: The U.S. Pharmaceutical Isolator Market Forecast by Value (2022-2026)
- 4.2 Europe
- 4.2.1 Europe Pharmaceutical Isolator Market by Value
- Table 21: Europe Pharmaceutical Isolator Market by Value (2017-2021)
- 4.2.2 Europe Pharmaceutical Isolator Market Forecast by Value
- Table 22: Europe Pharmaceutical Isolator Market Forecast by Value (2022-2026)
- 4.3 Asia Pacific
- 4.3.1 Asia Pacific Pharmaceutical Isolator Market by Value
- Table 23: Asia Pacific Pharmaceutical Isolator Market by Value (2017-2021)
- 4.3.2 Asia Pacific Pharmaceutical Isolator Market Forecast by Value
- Table 24: Asia Pacific Pharmaceutical Isolator Market Forecast by Value (2022-2026)
- 4.4 Latin America
- 4.4.1 Latin America Pharmaceutical Isolator Market by Value
- Table 25: Latin America Pharmaceutical Isolator Market by Value (2017-2021)
- 4.4.2 Latin America Pharmaceutical Isolator Market Forecast by Value
- Table 26: Latin America Pharmaceutical Isolator Market Forecast by Value (2022-2026)
- 5. Market Dynamics
- 5.1 Growth Drivers
- 5.1.1 Expansion of Biotechnology Industry
- Table 27: Global Biotechnology Market Share by Country (2021)
- 5.1.2 Explosive Growth of Cell & Gene Therapies in Development
- Table 28: Number of Cell & Gene Projects in Development Worldwide (2017-2021)
- 5.1.3 Increase in Use of High-potency Active Pharmaceutical Ingredients
- Table 29: Global High-potency Active Pharmaceutical Ingredients (2017-2021)
- 5.1.4 Rising Focus on Contract Development Manufacturing Organizations (CDMOs)
- Table 30: Global Contract Development Manufacturing Organizations (CDMOs) Sales (2020-2025)
- 5.1.5 Regulatory Framework to Support Adoption of Pharmaceutical Isolators
- 5.2 Key Trends & Developments
- 5.2.1 Growing Share of Isolators in Aseptic Manufacturing Market
- Table 31: Share of Isolators in Aseptic Manufacturing Market (2015-2025)
- 5.2.2 Upsurge in Pharmaceutical R&D Spending
- Table 32: Global Pharmaceutical R&D Spending (2021-2026)
- 5.2.3 Automation Inside Isolators
- 5.3 Challenges
- 5.3.1 Maintenance of Pharmaceutical Isolators
- 6. Competitive Landscape
- 6.1 Global Market
- 6.1.1 Key Players – Revenue Comparison
- Table 33: Key Players – Revenue Comparison (2021)
- 6.1.2 Key Players – Market Capitalization Comparison
- Table 34: Key Players – Market Capitalization Comparison (2022)
- 6.1.3 Global High-value Isolators Market Share by Company
- Table 35: Global High-value Isolators Market Share by Company (2021)
- 6.1.4 Global Premium Isolators Market Share by Company
- Table 36: Global Premium Isolators Market Share by Company (2021)
- 7. Company Profiles
- 7.1 Getinge
- 7.1.1 Business Overview
- 7.1.2 Financial Overview
- Table 37: Getinge Net Sales and Net Profit (Loss) (2017-2021)
- Table 38: Getinge Net Sales by Segment (2021)
- Table 39: Getinge Net Sales by Region (2021)
- 7.1.3 Business Strategies
- 7.2 Azbil
- 7.2.1 Business Overview
- 7.2.2 Financial Overview
- Table 40: Azbil Net Sales and Net Income (2017-2021)
- Table 41: Azbil Net Sales by Segment (2021)
- Table 42: Azbil Net Sales by Region (2021)
- 7.2.3 Business Strategies
- 7.3 Skan Holding
- 7.3.1 Business Overview
- 7.3.2 Financial Overview
- Table 43: Skan Holding Net Sales and Profit (2017-2021)
- Table 44: Skan Holding Net Sales by Segment (2021)
- Table 45: Skan Holding Net Sales by Region (2021)
- 7.3.3 Business Strategies
- 7.4 OPTIMA (METALL+PLASTIC)
- 7.4.1 Business Overview
- 7.4.2 Business Strategies
- 7.5 Syntegon Technology
- 7.5.1 Business Overview
- 7.5.2 Business Strategies
- 7.6 Comecer
- 7.6.1 Business Overview
- 7.6.2 Business Strategies